Health ❯ Medicine ❯ Pharmacology

Weight Loss

GLP-1 Medications GLP-1 Agonists GLP-1 Receptor Agonists Weight Loss Drugs Obesity Treatment Experimental Drugs GLP-1 Drugs Hormonal Treatments Appetite Suppression Genetic Influence Ozempic Wegovy Semaglutide Salcaprozate Sodium RNA Medicines Mounjaro Weight Loss Injections Anti-Obesity Medications Obesity Medications Tridecaneuropeptide (TDN) Weight-Loss Injections Tirzepatide

Resalis’ miR-22 Antisense Shows Durable Fat Loss in Animals as Phase 1 Trial Continues

Human safety and efficacy remain unproven beyond a company abstract at EASD.

Tufts Team Designs Experimental Four-Hormone Obesity Drug Aimed at Bigger, Gentler Weight Loss

Astrocyte-Derived Peptide Achieves Nausea-Free Weight Loss in Animal Models

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research